市場調查報告書

生物標記的全球市場規模調查

Global Biomarker Market Size study, by Disease Indication, by Application, by End-Use, by Product Type and Regional Forecasts 2018-2025

出版商 Bizwit Research & Consulting LLP 商品編碼 799106
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
Back to Top
生物標記的全球市場規模調查 Global Biomarker Market Size study, by Disease Indication, by Application, by End-Use, by Product Type and Regional Forecasts 2018-2025
出版日期: 2019年02月13日內容資訊: 英文
簡介

本報告以生物標記(生物指標物質)的全球市場為焦點,依疾病徵兆,用途,使用者,產品形式,地區別估算今後的交易規模,再分析形成其背景的法規環境和技術開發,供需,競爭趨勢等,並預測該市場的未來發展。

第1章 摘要整理

  • 市場簡述
  • 重要趨勢
  • 市場規模的估算與預測 - 全球整體及各市場區隔
    • 生物標記市場 - 疾病徵兆
    • 生物標記市場 - 各用途
    • 生物標記市場 - 使用者
    • 生物標記市場 - 產品形式
    • 生物標記市場 - 各地區
  • 估算方法
  • 調查的前提

第2章 生物標記市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 產業發展史
    • 調查的範圍
  • 預測對象年度
  • 貨幣換算比率

第3章 生物標記的市場動態

  • Seesaw分析
    • 市場推動要素
    • 市場課題
    • 市場發展機會

第4章 生物標記市場產業分析

  • 波特的五力分析模型
    • 買方議價能力
    • 賣主談判力
    • 新加入廠商者的威脅
    • 替代品的威脅
    • 競爭
    • 針對未來的波特五力分析活用法
  • PEST分析
    • 政治環境
    • 經濟環境
    • 社會環境
    • 技術環境
  • 價值鏈分析
    • 供應商
    • 廠商/服務供應商
    • 分銷商
    • 終端用戶
  • 買主的主要選擇標準
  • 法律規範
  • 原價結構分析
    • 原料費
    • 製造費
    • 人事費用
  • 比較投資的引進情形
  • 分析師的建議與結論

第5章 生物標記市場 - 各疾病徵兆

  • 市場簡述
  • 市場成績 - 有希望模式
  • 主要加入企業
  • 生物標記市場 - 各項目分析
    • 癌症
    • 心臟疾病
    • 感染性疾病
    • 神經疾病
    • 免疫疾病
    • 其他

第6章 生物標記市場 - 各用途

  • 市場簡述
  • 市場成績 - 有希望模式
  • 主要加入企業
  • 生物標記市場 - 各項目分析
    • 診斷
    • 藥物研發·藥物開發
    • 其他

第7章 生物標記市場 - 各使用者

  • 市場簡述
  • 市場成績 - 有希望模式
  • 主要加入企業
  • 生物標記市場 - 各項目分析
    • 醫院
    • 研究設施
    • 急救外科中心
    • 診斷測試設施

第8章 生物標記市場 - 產品形式

  • 市場簡述
  • 市場成績 - 有希望模式
  • 主要加入企業
  • 生物標記市場 - 各項目分析
    • 生物標記實驗套件
    • 生物標記分析設備

第9章 生物標記市場 - 各地區分析

  • 生物標記市場 - 地區市場簡述
  • 北美的生物標記市場簡述
    • 美國
    • 加拿大
  • 歐洲的生物標記市場簡述
    • 英國
    • 德國
    • 法國
    • 其他歐洲
  • 亞洲的生物標記市場簡述
    • 中國
    • 印度
    • 日本
    • 其他亞太地區
  • 南美的生物標記市場簡述
    • 巴西
    • 墨西哥
  • 其他地區
    • 南美
    • 中東·非洲

第10章 競爭資訊

  • 各企業市場佔有率
  • 有力市場對策
  • 企業簡介
    • Abbott Laboratories
    • Medtronic
    • BG Medicine Inc.
    • Hoffmann LA Roche Ltd.
    • Siemens Healthnineers
    • Nexus-DX
    • Qiagen N.V.
    • Lifesign LLC

第11章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場規模的估算
    • 檢驗
    • 出版
    • 調查的前提
目錄

Global Biomarker Market to reach USD XX billion by 2025.

Global Biomarker Market valued approximately USD 29.5 billion in 2017 is anticipated to grow with a healthy growth rate of more than 13% over the forecast period 2018-2025. The Biomarker Market is continuously growing in across the world over the upcoming years. Biomarker is a biological molecule or gene that is used to effectively and accurately evaluate pharmacologic responses, pathogenic procedures and biological procedures. It is also known as signature molecule or molecular marker. Increasing diagnostic applications of biomarkers, increasing R&D funding for pharma and biotech companies, increasing number of CROs and low cost of clinical trials in developing countries are the substantial driving factors of the market across the world. Furthermore, growing demand from emerging economies is creating numerous opportunity in the market over the upcoming years. Biomarkers are used to assist medical professionals to take effective clinical decisions and it also helps in diagnosing the health of patients. Also, biomarkers are predicting drug efficacy quickly than conventional clinical endpoints. These benefits of Biomarker also increasing demand among its end-user industries over the upcoming years. However, high capital investments and low cost-benefit ratio, poorly suited regulatory and reimbursement systems, and technical issues related to sample collection and storage is the restraining factors of the market across the globe.

The regional analysis of Global Biomarker Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region in the global Biomarker market due to growing prevalence of cancer and increasing adoption of precision medicine in the region. Europe is also estimated to grow in the global Biomarker market over the forecasted period 2018-2025. However, Asia-Pacific is also witnessed to grow at higher rate over the forecasted period 2018-2025.

The major market player included in this report are:

  • Abbott Laboratories
  • Medtronic
  • BG Medicine Inc.
  • Hoffmann LA Roche Ltd.
  • Siemens Healthnineers
  • Nexus-DX
  • Qiagen N.V.
  • Lifesign LLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Disease Indication:

  • Cancer, Cardiovascular Disorder
  • Infectious Diseases
  • Neurological Disorder
  • Immunological Disorder
  • Others

By Application:

  • Diagnosis
  • Drug Discovery and Development
  • Others

By End-Use:

  • Hospitals
  • Research Laboratories
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories

By Product Type:

  • Biomarker Test Kits
  • Biomarker Analyzers

By Regions:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2015, 2016

Base year - 2017

Forecast period - 2018 to 2025

Target Audience of the Global Biomarker Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

TABLE OF CONTENTS

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Key Trends
  • 1.3. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
    • 1.3.1. Biomarker Market, by Disease Indication, 2015-2025 (USD Billion)
    • 1.3.2. Biomarker Market, by Application, 2015-2025 (USD Billion)
    • 1.3.3. Biomarker Market, by End-Use, 2015-2025 (USD Billion)
    • 1.3.4. Biomarker Market, by Product Type, 2015-2025 (USD Billion)
    • 1.3.5. Biomarker Market, by Region, 2015-2025 (USD Billion)
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Biomarker Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Biomarker Market Dynamics

  • 3.1. See Saw Analysis
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Biomarker Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Buyers
    • 4.1.2. Bargaining Power of Suppliers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.2. PEST Analysis
    • 4.2.1. Political Scenario
    • 4.2.2. Economic Scenario
    • 4.2.3. Social Scenario
    • 4.2.4. Technological Scenario
  • 4.3. Value Chain Analysis
    • 4.3.1. Supplier
    • 4.3.2. Manufacturers/Service Provider
    • 4.3.3. Distributors
    • 4.3.4. End-Uses
  • 4.4. Key Buying Criteria
  • 4.5. Regulatory Framework
  • 4.6. Cost Structure Analysis
    • 4.6.1. Raw Material Cost Analysis
    • 4.6.2. Manufacturing Cost Analysis
    • 4.6.3. Labour Cost Analysis
  • 4.7. Investment Vs Adoption Scenario
  • 4.8. Analyst Recommendation & Conclusion

Chapter 5. Biomarker Market, by Disease Indication

  • 5.1. Market Snapshot
  • 5.2. Market Performance - Potential Model
  • 5.3. Key Market Players
  • 5.4. Biomarker Market, Sub Segment Analysis
    • 5.4.1. Cancer
      • 5.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.2. Cardiovascular Disorder
      • 5.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.3. Infectious Disease
      • 5.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.4. Neurological Disorder
      • 5.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.5. Immunological Disorder
      • 5.4.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 5.4.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 6. Biomarker Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Market Performance - Potential Model
  • 6.3. Key Market Players
  • 6.4. Biomarker Market, Sub Segment Analysis
    • 6.4.1. Diagnosis
      • 6.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.2. Drug Discovery and Development
      • 6.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 6.4.3. Others
      • 6.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 6.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 7. Biomarker Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Market Performance - Potential Model
  • 7.3. Key Market Players
  • 7.4. Biomarker Market, Sub Segment Analysis
    • 7.4.1. Hospitals
      • 7.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.2. Research Laboratories
      • 7.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.3. Ambulatory Surgical Centers
      • 7.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 7.4.4. Diagnostic Laboratories
      • 7.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 7.4.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 8. Biomarker Market, by Product Type

  • 8.1. Market Snapshot
  • 8.2. Market Performance - Potential Model
  • 8.3. Key Market Players
  • 8.4. Biomarker Market, Sub Segment Analysis
    • 8.4.1. Biomarker Test Kits
      • 8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 8.4.2. Biomarker Analyzers
      • 8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 8.4.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Biomarker Market, by Regional Analysis

  • 9.1. Biomarker Market, Regional Market Snapshot (2015-2025)
  • 9.2. North America Biomarker Market Snapshot
    • 9.2.1. U.S.
      • 9.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.2.2. Canada
      • 9.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.2.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.3. Europe Biomarker Market Snapshot
    • 9.3.1. U.K.
      • 9.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.1.6.
    • 9.3.2. Germany
      • 9.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.3.3. France
      • 9.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.3.4. Rest of Europe
      • 9.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.3.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.4. Asia Biomarker Market Snapshot
    • 9.4.1. China
      • 9.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.4.2. India
      • 9.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.4.3. Japan
      • 9.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.3.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.4.4. Rest of Asia Pacific
      • 9.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.4.4.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.5. Latin America Biomarker Market Snapshot
    • 9.5.1. Brazil
      • 9.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.5.2. Mexico
      • 9.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.5.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
  • 9.6. Rest of The World
    • 9.6.1. South America
      • 9.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.1.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    • 9.6.2. Middle East and Africa
      • 9.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.2. Disease Indication breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.3. Application breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.4. End-Use breakdown estimates & forecasts, 2015-2025 (USD Billion)
      • 9.6.2.5. Product Type breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 10. Competitive Intelligence

  • 10.1. Company Market Share (Subject to Data Availability)
  • 10.2. Top Market Strategies
  • 10.3. Company Profiles
    • 10.3.1. Abbott Laboratories
      • 10.3.1.1. Overview
      • 10.3.1.2. Financial (Subject to Data Availability)
      • 10.3.1.3. Summary
      • 10.3.1.4. Recent Developments
    • 10.3.2. Medtronic
    • 10.3.3. BG Medicine Inc.
    • 10.3.4. Hoffmann LA Roche Ltd.
    • 10.3.5. Siemens Healthnineers
    • 10.3.6. Nexus-DX
    • 10.3.7. Qiagen N.V.
    • 10.3.8. Lifesign LLC

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
    • 11.1.6. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF BIOMARKER MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF BIOMARKER MARKET
  • TABLE 3. BIOMARKER MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. BIOMARKER MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
  • TABLE 7. BIOMARKER MARKET ESTIMATES & FORECASTS BY COMPONENT 2015-2025 (USD BILLION)
  • TABLE 8. BIOMARKER MARKET ESTIMATES & FORECASTS BY Disease Indication 2015-2025 (USD BILLION)
  • TABLE 9. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 10. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 11. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 12. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 13. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 14. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 15. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 16. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 17. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 18. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 19. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 20. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 21. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 22. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 23. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 24. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 25. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 26. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 27. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 28. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 29. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 30. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 31. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 32. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 33. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 34. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 35. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 36. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 37. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 38. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 39. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 40. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 41. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 42. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 43. BIOMARKER MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 44. BIOMARKER MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 45. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 46. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 47. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 48. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 49. U.S. BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 50. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 51. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 52. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 53. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 54. CANADA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 55. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 56. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 57. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 58. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 59. UK BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 60. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 61. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 62. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 63. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 64. GERMANY BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 65. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 66. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 67. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 68. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 69. ROE BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 70. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 71. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 72. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 73. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 74. CHINA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 75. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 76. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 77. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 78. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 79. INDIA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 80. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 81. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 82. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 83. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 84. JAPAN BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 85. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 86. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 87. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 88. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 89. ROAPAC BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 90. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 91. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 92. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 93. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 94. BRAZIL BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 95. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 96. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 97. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 98. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 99. MEXICO BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 100. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 101. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 102. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 103. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 104. ROLA BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 105. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
  • TABLE 106. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 107. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 108. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
  • TABLE 109. ROW BIOMARKER MARKETMARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

List of Figures

  • FIG 1. BIOMARKER MARKET, RESEARCH METHODOLOGY
  • FIG 2. BIOMARKER MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. BIOMARKER MARKET, KEY TRENDS 2016
  • FIG 5. BIOMARKER MARKET, GROWTH PROSPECTS 2017-2025
  • FIG 6. BIOMARKER MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. BIOMARKER MARKET, PEST ANALYSIS
  • FIG 8. BIOMARKER MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 10. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 11. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 12. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 13. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 14. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 15. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 16. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 17. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 18. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 19. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 20. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 21. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 22. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 23. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 24. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 25. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 26. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 27. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 28. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 29. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 30. BIOMARKER MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
  • FIG 31. BIOMARKER MARKET, REGIONAL SNAPSHOT 2015 & 2025
  • FIG 32. NORTH AMERICA BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 33. EUROPE BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 34. ASIA PACIFIC BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 35. LATIN AMERICA BIOMARKER MARKETMARKET 2015 & 2025 (USD BILLON)
  • FIG 36. BIOMARKER MARKET, COMPANY MARKET SHARE ANALYSIS (2016)
Back to Top